The new world of human genetic technologies: The policy environment and impacts of genetic screening tests [Book Review]
David Bourget (Western Ontario)
David Chalmers (ANU, NYU)
Rafael De Clercq
Jack Alan Reynolds
Learn more about PhilPapers
AI and Society 9 (1):105-114 (1995)
Today it is possible to screen for mutated DNA sequences which do not induce any diseases but predispose to develop diseases under certain environmental condition. These latter disorders are called multifactorial since they result from the interplay of genetic and environmental factors. Among multifactorial disorders there are job-related diseases whose genetic component can be identified by genetic screening tests. The use of these tests to predict occupational disorders, to cut down on them, and to save costsâin particular for absenteeism, health care, and lawsuitsâis of interest to employers and insurers. As for employees, it could entail an extremely deep invasion of privacy, economic problems and, very likely, a jeopardy of the present position of the individual who may be screened even if his/her potential disease is never developed
|Keywords||Genetic disorder Multifactorial disease Job-related disease Genetic screening test Technology assessment|
|Categories||categorize this paper)|
|Through your library||Configure|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Robert H. Blank (1982). Public Policy Implications of Human Genetic Technology: Genetic Screening. Journal of Medicine and Philosophy 7 (4):355-374.
Ludvig Beckman (2004). Are Genetic Self-Tests Dangerous? Assessing the Commercialization of Genetic Testing in Terms of Personal Autonomy. Theoretical Medicine and Bioethics 25 (5-6):387-398.
Ruth Chadwick, Henk ten Have, Jfrgen Husted, Mairi Levitt, Tony McGleenan, Darren Shickle & Urban Wiesing (1998). Genetic Screening and Ethics: European Perspectives. Journal of Medicine and Philosophy 23 (3):255 – 273.
Joseph Kupfer (1993). The Ethics of Genetic Screening in the Workplace. Business Ethics Quarterly 3 (1):17-25.
Joseph S. Alper & Jon Beckwith (1998). Distinguishing Genetic From Nongenetic Medical Tests: Some Implications for Antidiscrimination Legislation. Science and Engineering Ethics 4 (2):141-150.
Barabara Biesecker (1998). Future Directions in Genetic Counseling: Practical and Ethical Considerations. Kennedy Institute of Ethics Journal 8 (2):145-160.
Ayodele S. Jegede (2009). Culture and Genetic Screening in Africa. Developing World Bioethics 9 (3):128-137.
Claudia Wild (2008). Polymorphism-Screening: Genetic Testing for Predisposition—Guidance for Technology Assessment. [REVIEW] Poiesis and Praxis 5 (1):1-14.
G. T. Laurie (2002). Genetic Privacy: A Challenge to Medico-Legal Norms. Cambridge University Press.
Inmaculada de Melo-Martín (2006). Genetic Testing: The Appropriate Means for a Desired Goal? [REVIEW] Journal of Bioethical Inquiry 3 (3):167-177.
Susan Lindee & Rebecca Mueller (2011). Is Cystic Fibrosis Genetic Medicine's Canary? Perspectives in Biology and Medicine 54 (3):316-331.
Felix Thiele (2003). Genetic Tests in the Insurance System: Criteria for a Moral Evaluation. Poiesis and Praxis 1 (3):185-195.
David L. Wiesenthal & Neil I. Wiener (1996). Privacy and the Human Genome Project. Ethics and Behavior 6 (3):189 – 202.
Alan Strudler (1994). The Social Construction of Genetic Abnormality: Ethical Implications for Managerial Decisions in the Workplace. [REVIEW] Journal of Business Ethics 13 (11):839 - 848.
Added to index2010-08-30
Total downloads3 ( #224,108 of 1,088,907 )
Recent downloads (6 months)1 ( #69,735 of 1,088,907 )
How can I increase my downloads?